Business Description
![Marizyme Inc Marizyme Inc logo](https://static.gurufocus.com/logos/0C000018KJ.png?14)
Marizyme Inc
NAICS : 325412
SIC : 2834
ISIN : US5703721028
Description
Marizyme Inc is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical device technologies that improve patient health outcomes. Currently, the company is focused on developing three medical technology products: DuraGraft, Krillase, and MATLOC. DuraGraft is a single-use intraoperative vascular graft treatment that protects against ischemic injury and reduces the incidence and complications of graft failure, MATLOC is a point-of-care, lab-on-chip digital screening, and diagnostic device platform, initially being developed for quantitative chronic kidney disease, or CKD, assessment, and Krillase protein enzyme provides a therapeutics opportunity for wound healing, thrombosis, and pet health.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -0.44 | |||||
Debt-to-Equity | -2.18 | |||||
Debt-to-EBITDA | -0.71 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -16.24 | |||||
Beneish M-Score | -12.76 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26 | |||||
3-Year EBITDA Growth Rate | -56.4 | |||||
3-Year EPS without NRI Growth Rate | -78.7 | |||||
3-Year FCF Growth Rate | 7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.32 | |||||
9-Day RSI | 36.55 | |||||
14-Day RSI | 37.47 | |||||
6-1 Month Momentum % | -28.57 | |||||
12-1 Month Momentum % | -50 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.04 | |||||
Quick Ratio | 0.04 | |||||
Days Inventory | 203.07 | |||||
Days Sales Outstanding | 63.33 | |||||
Days Payable | 8125.56 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -54.2 | |||||
Shareholder Yield % | -316.24 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 69.95 | |||||
Operating Margin % | -4334.97 | |||||
Net Margin % | -14348.36 | |||||
FCF Margin % | -1068.03 | |||||
ROA % | -188.87 | |||||
ROIC % | -30.49 | |||||
ROC (Joel Greenblatt) % | -2688.67 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.57 | |||||
EV-to-EBIT | -0.83 | |||||
EV-to-EBITDA | -0.85 | |||||
EV-to-Revenue | 67.4 | |||||
EV-to-FCF | -6.31 | |||||
Earnings Yield (Greenblatt) % | -120.48 | |||||
FCF Yield % | -92.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MRZM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Marizyme Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.366 | ||
EPS (TTM) ($) | -0.95 | ||
Beta | -0.55 | ||
Volatility % | 107.71 | ||
14-Day RSI | 37.47 | ||
14-Day ATR ($) | 0.001822 | ||
20-Day SMA ($) | 0.03406 | ||
12-1 Month Momentum % | -50 | ||
52-Week Range ($) | 0.0288 - 0.405 | ||
Shares Outstanding (Mil) | 131.79 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Marizyme Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Marizyme Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Marizyme Inc Frequently Asked Questions
What is Marizyme Inc(MRZM)'s stock price today?
The current price of MRZM is $0.03. The 52 week high of MRZM is $0.41 and 52 week low is $0.03.
When is next earnings date of Marizyme Inc(MRZM)?
The next earnings date of Marizyme Inc(MRZM) is 2024-11-14 Est..
Does Marizyme Inc(MRZM) pay dividends? If so, how much?
Marizyme Inc(MRZM) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |